SICHUAN KELUN-BIOTECH BIOPHARMACEUT revenue for the last year amounted to 1.69 B HKD, the most of which — 1.70 B HKD — came from its highest performing source at the moment, Novel Drugs, the year earlier bringing 934.88 M HKD. The greatest contribution to the revenue figure was made by United States — last year it brought SICHUAN KELUN-BIOTECH BIOPHARMACEUT 1.69 B HKD, and the year before that — 848.94 M HKD.